82 results
8-K
AXLA
Axcella Health Inc.
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
Listing Rule 5605(b)(1); the audit committee composition requirement under Listing Rule 5605(c)(2); the compensation committee composition requirement
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
16(a) Reports
Report of the Audit Committee
General Matters
AXCELLA HEALTH INC. D/B/A AXCELLA THERAPEUTICS
P.O. Box 1270
Littleton, Massachusetts … asked to ratify the appointment by the audit committee of the board of directors of Deloitte & Touche LLP as Axcella’s independent registered public
8-K
EX-10.1
pzcz0a 1mws
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
EX-10.1
jx4lj6
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm